Cytotherapy and Longevity is an Open-Access journal supported by article processing charges (APCs).
Cytotherapy and Longevity levies an Article Processing Charge (APC) per article. Only accepted papers will be charged. Authors whose work is accepted for publication are responsible for paying an APC.
The APC for all published articles is as follows Cytotherapy and Longevity offers APC waivers before December 31, 2029.
The consideration of your submission for publication will remain unaffected by your request for fee support. All submissions are evaluated solely based on scientific merit, originality, and relevance to the journal's scope.